BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7877864)

  • 1. [Role of chemoprophylaxis in the prevention of invasive aspergillosis].
    Joly V
    Pathol Biol (Paris); 1994 Sep; 42(7):694-9. PubMed ID: 7877864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Curative treatment of invasive aspergillosis].
    Dupont B
    Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.
    Gubbins PO; Bowman JL; Penzak SR
    Pharmacotherapy; 1998; 18(3):549-64. PubMed ID: 9620106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Invasive bronchopulmonary aspergillosis treated with itraconazole in a patient with acute leukemia].
    Sarcía-Ruiz JC; Alvarez C; Floristán F; Hernández I; Hernández J; Alvarez Blanco A; Ponton J
    Sangre (Barc); 1993 Oct; 38(5):399-402. PubMed ID: 8140504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aspergillosis in pulmonary transplantation].
    de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
    Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug perspectives in the treatment of invasive aspergillosis].
    Yeni P
    Pathol Biol (Paris); 1994 Sep; 42(7):700-5. PubMed ID: 7877865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Invasive aspergillosis and bone marrow allograft].
    Ribaud P; Esperou-Bourdeau H; Devergie A; Gluckman E
    Pathol Biol (Paris); 1994 Sep; 42(7):652-5. PubMed ID: 7877857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
    Myoken Y; Sugata T; Kyo T; Fujihara M; Mikami Y
    J Periodontol; 2002 Jan; 73(1):33-8. PubMed ID: 11846198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
    Martino R; Nomdedéu J; Altés A; Sureda A; Brunet S; Martínez C; Domingo-Albós A
    Bone Marrow Transplant; 1994 Mar; 13(3):265-9. PubMed ID: 8199569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters.
    Oren I; Haddad N; Finkelstein R; Rowe JM
    Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Controversy concerning optimal prophylaxis and empirical antifungal therapy in immunocompromised patients].
    Zielińska E
    Przegl Epidemiol; 2003; 57(2):299-307. PubMed ID: 12910598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized amphotericin B in prophylaxis of pulmonary aspergillosis.
    Tsourounis C; Guglielmo BJ
    Ann Pharmacother; 1996 Oct; 30(10):1175-6. PubMed ID: 8893125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant itraconazole in the treatment of destructive sphenoid aspergillosis.
    Rowe-Jones JM; Freedman AR
    Rhinology; 1994 Dec; 32(4):203-7. PubMed ID: 7701229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
    Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
    Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.